Log In
Print
BCIQ
Print
Print this Print this
 

ARX788

  Manage Alerts
Collapse Summary General Information
Company Ambrx Inc.
DescriptionAntibody-drug conjugate (ADC) targeting epidermal growth factor receptor 2 (EGFR2; HER2)
Molecular Target Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today